[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 1958

Synthesis and Metabolism of Radioactive Heparin

Author Affiliations

New York

The Gilman Laboratory is a part of New York Medical College, Flower and Fifth Avenue Hospitals. Department of Medicine (Dr. Eiber) and Department of Biochemistry (Dr. Danishefsky).

AMA Arch Intern Med. 1958;102(2):189-193. doi:10.1001/archinte.1958.00260200017003

Introduction  Heparin synthesis, metabolism, and fate has been an enigma for many years. The following paper is based on the results of a three-year biochemical and clinical study of this fascinating substance. New methods of study were established, including the synthesis and experimental use of radioactive heparin in an effort to elucidate its many problems.Heparin has been employed clinically for a number of years in the treatment of thrombosis. The rationale for its application is the fact that it is an extremely potent inhibitor of blood coagulation, and consequently it may be expected to be beneficial in thromboembolic diseases. Its effect as an anticoagulant is almost immediate, and it is therefore extremely useful where rapid action is required.1 Heparin acts primarily on one of the later stages of blood coagulation, i. e., it inhibits the formation of thrombin from prothrombin and, to some extent, prevents thrombin from converting

First Page Preview View Large
First page PDF preview
First page PDF preview